Paula Dobosz
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
-
- RNA modifications and cancer 4
- Oncology 11
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 3
- Co-authors
- Tomasz Dzieciątkowski (3 shared papers)Anna Golke (1 shared paper)Magdalena Mroczek (10 shared papers)Dror Avni (3 shared papers)Raya Leibowitz‐Amit (3 shared papers)Przemysław Stempor (3 shared papers)Yechezkel Sidi (3 shared papers)Martyna Borowczyk (7 shared papers)
- Journals
- International Journal of Molecular Sciences (7 papers)Frontiers in Immunology (3 papers)Cancers (2 papers)Pharmaceutics (1 paper)PLoS ONE (1 paper)
- Partner nations
- PolandUnited KingdomSwitzerland
In The Last Decade
Paula Dobosz
26 papers receiving 514 citations
Peers
Comparison fields: 5 of 76
- Oncology 251
- Immunology 192
- Biotechnology 31
- Cancer Research 35
- Molecular Biology 135
Countries citing papers authored by Paula Dobosz
This map shows the geographic impact of Paula Dobosz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula Dobosz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula Dobosz more than expected).
Fields of papers citing papers by Paula Dobosz
This network shows the impact of papers produced by Paula Dobosz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula Dobosz. The network helps show where Paula Dobosz may publish in the future.
Co-authors
The 25 scholars most cited alongside Paula Dobosz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 298 | |
| 2 | 2022 | 73 | |
| 3 | 2024 | 24 | |
| 4 | 2019 | 20 | |
| 5 | 2019 | 20 | |
| 6 | 2010 | 18 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 8 | |
| 9 | 2021 | 6 | |
| 10 | 2023 | 6 | |
| 11 | 2022 | 6 | |
| 12 | 2017 | 6 | |
| 13 | 2023 | 5 | |
| 14 | 2022 | 4 | |
| 15 | 2022 | 3 | |
| 16 | 2022 | 2 | |
| 17 | 2024 | 2 | |
| 18 | 2025 | 2 | |
| 19 | 2024 | 1 | |
| 20 | 2024 | 1 |
About Paula Dobosz
Paula Dobosz is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Infectious Diseases, having authored 30 papers that have together received 521 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Immunotherapy and Immune Responses (4 papers), RNA modifications and cancer (4 papers), Cancer Genomics and Diagnostics (3 papers), Ferroptosis and cancer prognosis (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers), CAR-T cell therapy research (3 papers) and Genetic factors in colorectal cancer (3 papers). The work is most often cited by research in Oncology (251 citations), Immunology (192 citations), Biotechnology (31 citations), Cancer Research (35 citations) and Molecular Biology (135 citations). Paula Dobosz has collaborated with scholars based in Poland, United Kingdom and Switzerland. Frequent co-authors include Tomasz Dzieciątkowski, Anna Golke, Magdalena Mroczek, Dror Avni, Raya Leibowitz‐Amit, Przemysław Stempor, Yechezkel Sidi, Martyna Borowczyk, Jason Roszik and Raanan Berger. Their work appears in journals such as International Journal of Molecular Sciences, Frontiers in Immunology, Cancers, Pharmaceutics and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.